Celliance Corporation - - BioPharm International

ADVERTISEMENT

Celliance Corporation

BioPharm International
Volume 18, Issue 12

Company Description



Celliance offers an expanding array of bioprocessing products and services including diagnostic products, cell culture media supplements, and contract manufacturing services. The company's customers include many of the leading biopharmaceutical companies worldwide who have brought FDA-approved products to the market using Celliance's products and technologies. Celliance's products help accelerate the movement of critical therapeutic drugs from the laboratory to the marketplace. Celliance is a Serologicals company based in Atlanta, GA.

Facilities

Located in North America and the United Kingdom, the company's manufacturing facilities represent a quality commitment to our customers. The Kankakee, IL, Toronto, Canada, and Lawrence, KS facilities produce a variety of proteins and other supplements used in diagnostic reagents and cell culture media. The company's facility in Scotland develops and manufactures monoclonal antibodies for use in diagnostic products.

Products

The EX-CYTE growth enhancement media supplement provides a balanced profile of metabolic factors proven to enhance cell growth and protein production in a variety of mammalian cells.



Probumin BSA: With over 30 application-specific grades of bovine albumin, Celliance is one of the world's largest and most experienced manufacturer of high quality bovine albumin.

Incelligent Insulin: Celliance is the leading provider of Incelligent recombinant human insulin to the bioprocessing industry.

MonoSera Monoclonal Antibodies

Celliance is a leading manufacturer of monoclonal antibodies for the blood-typing industry. Celliance has over 60 monoclonal antibodies and over 20 years of expertise in the manufacture of monoclonal antibodies and finished blood-typing reagents.

CELLIANCE CORPORATION
5655 Spalding Drive Norcross, GA 30092

TELEPHONE
North America: 800.431.4505
All Others: 678.728.2246

FAX
North America: 800.468.7436
All Others: 678.728.2247

E-MAIL

WEB ADDRESS
http://www.celliancecorp.com/

blog comments powered by Disqus

ADVERTISEMENT

Pfizer Wins Multibillion-Dollar Settlement from Teva and Sun for Infringement of Protonix Patent
June 19, 2013
Elan Proceeds with Formal Sale Process of Company; Royalty Pharma Drops Bid
June 19, 2013
J&J to Acquire Aragon Pharmaceuticals
June 19, 2013
AstraZeneca Selects Cambridge, UK for New Global R&D Center and Corporate HQ
June 19, 2013
GSK Receives Offer for its Thrombosis Brands and Related Manufacturing Site
June 19, 2013
Upcoming Conferences
UPCOMING CONFERENCES

Access Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA | July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA | August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA | August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA | August 20-21, 2013
Request Brochure

See All Conferences >>

ADVERTISEMENT

Author Guidelines
FindPharma
Source: BioPharm International,
Click here